A
Axel Zeeck
Researcher at University of Göttingen
Publications - 318
Citations - 8002
Axel Zeeck is an academic researcher from University of Göttingen. The author has contributed to research in topics: Streptomyces & Metabolite. The author has an hindex of 44, co-authored 318 publications receiving 7501 citations. Previous affiliations of Axel Zeeck include Andhra University & Novartis.
Papers
More filters
Journal ArticleDOI
Big effects from small changes: Possible ways to explore nature's chemical diversity
TL;DR: The systematic alteration of easily accessible cultivation parameters in order to increase the number of secondary metabolites available from one microbial source is investigated and the OSMAC approach seems to be a useful tool to detect those metabolites that are postulated to be the final products of an amazing number of typical secondary metabolites gene clusters identified in several microorganisms.
Journal ArticleDOI
Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c.
Markus Huss,Gudrun Ingenhorst,Simone König,Michael Gaßel,Stefan Dröse,Axel Zeeck,Karlheinz Altendorf,Helmut Wieczorek +7 more
TL;DR: Binding of J-concanolide A to subunit c was prevented in a concentration-dependent manner by concanamycin A, indicating that labeling was specific, and binding was also prevented by the plecomacrolides bafilomycin A1 and B1, respectively.
Journal ArticleDOI
The structures of antioxidant and cytotoxic agents from natural source: anthraquinones and tannins from roots of Rumex patientia.
TL;DR: A new anthraquinone glycoside, emodin-6-O-beta-D-glucopyranoside, and a new simple halogenated flavan-3-ol, 6-chlorocatechin, have been isolated from the roots of Rumex patientia L. together with seven known phenolic compounds.
Journal ArticleDOI
Archazolid and apicularen : novel specific V-ATPase inhibitors
Markus Huss,Florenz Sasse,Brigitte Kunze,R. Jansen,Heinrich Steinmetz,Gudrun Ingenhorst,Axel Zeeck,Helmut Wieczorek +7 more
TL;DR: The myxobacterial antibiotics archazolid and apicularen are highly efficient and specific novel inhibitors of V-ATPases.
Journal ArticleDOI
Metabolic products of microorganisms. 234 urdamycins, new angucycline antibiotics from streptomyces fradiae
TL;DR: The colored urdamycins A to F, six new angucycline antibiotics produced by Streptomyces fradiae strain Tu 2717, were detected by chemical screening and are biologically active against Gram-positive bacteria and stem cells of murine L1210 leukemia.